This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Ninth Circuit affirms dismissal of qui tam suit against Allergan

( January 30, 2025, 15:35 GMT | Official Statement) -- MLex Summary: The US Court of Appeals for the Ninth Circuit affirmed a lower court decision that patent attorney Zachary Silbersher's quit tam action against Allergan should be dismissed as it did not pass the public information bar. Silbersher accused Allergan of defrauding Medicare and Medicaid and overcharging the federal government by acquiring fraudulent patents for two Alzheimer's medications.See the order attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections